Jingxin Pharmaceutical: 2023 Annual Debriefing Report of the Company's Independent Directors (Zhang Daliang)

SZSI · Mar 30

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.